Dr. Reddy’s Laboratories Ltd ADR annual gross profit for fiscal TTM was ₹166.9 billion, a decrease of 10.5% from ₹186.5 billion in fiscal 2026. All figures are reported results from public filings — no estimates or projections.
| Gross Profit (annual) | TTM → 2026-06-30 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 | 2016-03-31 | 2015-03-31 | 2014-03-31 | 2013-03-31 | 2012-03-31 | 2011-03-31 | 2010-03-31 | 2009-03-31 | 2008-03-31 | 2007-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Profit | ₹166.9B | ₹186.5B | ₹190.4B | ₹163.6B | ₹139.3B | ₹113.8B | ₹1.3B | ₹94.0B | ₹83.4B | ₹76.3B | ₹78.4B | ₹92.3B | ₹85.4B | ₹75.8B | ₹60.6B | ₹53.3B | ₹40.3B | ₹36.3B | ₹36.5B | ₹25.4B | ₹30.9B |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Gross Profit (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Gross Profit | ₹37.8B | ₹34.2B | ₹46.8B | ₹48.1B | ₹48.6B | ₹47.3B | ₹49.1B | ₹47.8B |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More RDY metrics: Revenue · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All RDY financial statements → Interactive RDY charts →
About TickerBase · Data methodology & sources · Privacy · Terms